Clal Biotechnological Industries Ltd. is a wholly owned subsidiary of Clal Industries and Investments Ltd. CBI is the leading Israeli investor in the area of life science. It was established in 1998, and has invested to date mainly in mature companies. Portfolio companies include: D-Pharm, Compugen (Nasdaq:CGEN), NST, Polyheal, Peptor, Immuno-Designed Molecules (France), OralScan Laboratories (USA) and MTRE Advanced Technologies.
MPM Capital L.P. is a global asset management firm focused solely on healthcare investing from early stage start-ups to large capitalization public companies. MPM’s current portfolio consists of biopharmaceutical and medical devices companies and encompasses platform technology as well as product plays. The firm has over $1 billion in assets under management through $800 million in the MPM BioVentures family of venture capital funds and $400 million in MPM BioEquities, a fund investing in public healthcare companies. These combined funds make MPM Capital one of the largest asset management firms dedicated to the life sciences sector
